Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
NEW YORK, Oct 26, 2005 /PRNewswire-FirstCall via COMTEX/ -- International Flavors & Fragrances Inc. (NYSE: IFF) ("IFF" or "the Company") reported earnings per share for the third quarter 2005 of $.72 compared to $.44 in the prior year quarter. The 2005 third quarter results include a net tax benefit of $23.3 million ($.24 per share) relating to the Company's intention to repatriate, in 2005, approximately $250 million of dividends from foreign subsidiaries under the provisions of the American Jobs Creation Act of 2004 ("AJCA"). On an as-adjusted basis, excluding the tax impact noted above, 2005 third quarter earnings per share would have been $.48. The 2004 third quarter results include $20.0 million ($12.7 million after tax or $.14 per share) of restructuring and other charges related to the sale of certain European fruit business assets, the closure of the Company's Dijon, France manufacturing facility and other related reorganization activities. On an as-adjusted basis, excluding both the sales and operating results of the fruit business and the effects of the charges related to the disposition thereof, 2004 third quarter earnings per share would have been $.58.
Third quarter 2005 sales totaled $493.1 million, declining 3% in comparison to the prior year in both local currency and reported dollars. Fragrance and flavor sales decreased 1% and 3%, respectively, in both local currency and dollars.
Flavor sales in the 2005 quarter were impacted by the disposition, in the second half of 2004, of the Company's European fruit preparations business. On an as-adjusted basis, excluding $10.6 million in sales attributable to the fruit business from the 2004 third quarter, flavor sales for the current quarter would have increased 2% in dollars and 1% in local currency. Flavor sales, most notably in North America and Europe, were also unfavorably impacted by lower selling prices for naturals, mainly vanilla.
Fragrance sales were led by fine fragrance which increased 1% in both local currency and dollars; the fine fragrance performance reflected the benefit of new product wins. Chemical sales decreased 5% in both local currency and dollars while sales of functional fragrances were flat in both local currency and dollars.
"Our growth with IFF's largest global accounts gives me confidence that our long-term strategic initiatives will enable us to successfully manage through the current challenging pricing environment," said Richard A. Goldstein, Chairman and Chief Executive Officer of IFF. "Year-to-date, local currency sales to our 5 largest customers have grown by over 6%, following 7% growth for the full year 2004. Innovative technologies, combined with our collaborative approach to working with our customers will prove to be important differentiators. With our customer partnerships and continued technology leadership, we are well positioned to achieve our goals and drive value for IFF shareholders."
Sales performance by region for the 2005 third quarter compared to the prior year quarter follows:
- North America fragrance and flavor sales declined 2% and 10%, respectively; in total, regional sales declined 5%. Fine fragrance and aroma chemical sales increased 6% and 1%, respectively, while functional fragrances decreased 8%. New fragrance wins drove the fine fragrance performance.
- European fragrance and flavor sales decreased 3% and 14%, respectively; in total, regional sales declined 7%. Local currency fragrance sales decreased 3%; aroma chemical sales decreased 10%, functional fragrance sales were flat, while fine fragrance sales increased 1%. Local currency flavor sales declined 13%, mainly as a result of the disposition of the fruit preparations business. On an as-adjusted basis, excluding sales attributable to this business from the 2004 results, 2005 flavor sales would have been flat in dollars and increased 1% in local currency. On the same as-adjusted basis, sales in Eastern Europe increased 21% in local currency, led by a 42% increase in Russia; however, this performance was offset by a local currency decline of 3% in Western Europe.
- Asia Pacific sales increased 2% in local currency and 3% in dollars. Fragrance sales decreased 6% in both local currency and dollars; flavor sales increased 7% in local currency and 9% in dollars. Local currency fine and functional fragrance sales declined 15% and 6%, respectively, mainly due to weak demand in Singapore, Thailand and Australia. Flavor sales were led by Greater China, Vietnam and Indonesia with respective local currency sales increases of 28%, 72% and 17%. For the region, Greater China, Vietnam, the Philippines and Indonesia were strongest, with respective local currency sales increases of 8%, 31%, 18% and 9%.
- Latin American sales increased 10% with fragrance and flavor sales increasing 3% and 34%, respectively. Flavor sales were strongest in Argentina, Brazil and Mexico which grew 48%, 39% and 53%, respectively. Functional fragrance and aroma chemical sales increased 6% and 2%, respectively, while fine fragrance sales decreased 6%; fragrance growth was generally consistent among all countries.
- India reported sales growth of 18% in both local currency and dollars. Local currency fragrance sales increased 16% and 15% in dollars, while flavor sales increased 21% in both local currency and dollars. In both flavors and fragrances, the sales performance reflected the benefit of new product introductions.
Net income for the 2005 third quarter increased 62% compared to the prior year quarter. The 2005 third quarter results include a tax benefit of $23.3 million ($.24 per share) relating to AJCA; the tax benefit results from the reversal of prior accruals relating to the repatriation of foreign earnings, net of the applicable reduced U.S. tax cost of eligible repatriated foreign earnings, as provided for in AJCA. The 2004 third quarter results include $20.0 million ($12.7 million after tax or $.14 per share) of restructuring and other charges related to the sale of certain European fruit business assets, the closure of the Company's Dijon, France manufacturing facility and other related reorganization activities. Excluding the impact of restructuring and other charges from the 2004 results and the tax benefit from AJCA from the 2005 results, net income would have decreased 18%.
In the third quarter, gross profit as a percentage of sales was 41.9% compared to 42.9% in the prior year; the margin decline was mainly attributable to higher raw material costs which the Company has not yet been able to fully recover through increased selling prices. Research and Development ("R&D") expenses totaled 9.1% of sales compared to 8.5% in the prior year quarter, consistent with the Company's intended level of R&D spending. Selling, General and Administrative ("SG&A") expenses, as a percentage of sales, increased to 17.4% from 16.5% due to the cost of customer damages related to the raw material contamination issue the Company reported earlier this year and for which the Company will seek full indemnification from its supplier, the supplier's insurers and, to the extent required, its own insurers. Interest expense increased 9% from the prior year due to higher borrowing levels during the quarter and somewhat higher cost of borrowing. The effective tax rate for the 2005 third quarter was significantly impacted by the benefit attributable to AJCA; excluding this benefit, discussed above, the effective tax rate for the quarter would have been 31.7% compared to 29.9% in the prior year quarter. Variations in the effective tax rate are mainly attributable to fluctuations in earnings in the countries in which the Company operates.
For the nine-month period ended September 30, 2005, sales totaled $1,531.7 million, declining 2% in comparison to the prior year period, as reported. Reported sales for 2005 benefited from the strengthening of various currencies, particularly the Euro, in relation to the U.S. dollar; had exchange rates remained constant, sales for the nine-month period ended September 30, 2005 would have decreased 3% compared to the prior year period. For the 2005 period, fragrance sales increased 2% while flavor sales declined 7%; on a local currency basis, fragrance sales grew 1% while flavor sales declined 9%.
Flavor sales in the 2005 period were impacted by the disposition, in the second half of 2004, of the Company's European fruit preparations business. On an as-adjusted basis, excluding $56.8 million in sales attributable to the fruit business from the 2004 period, 2005 flavor sales would have increased 1% in dollars and declined 1% in local currency. Flavor sales, most notably in North America and Europe, were also unfavorably impacted by lower selling prices for naturals, mainly vanilla, as well as a $5.0 million impact in the second quarter related to a raw material contamination issue.
Sales performance by region for the 2005 nine-month period compared to the prior year follows:
- North America fragrance and flavor sales declined 2% and 9%, respectively; in total, regional sales declined 5%. Fine fragrance and aroma chemical sales both increased 2%, while functional fragrance sales declined 6%. Sales of both fragrances and flavors had a difficult comparative with the 2004 period when sales increased 11% and 13%, respectively.
- Europe sales declined 9% in local currency and 6% in dollars. Fragrance sales increased 1% in local currency and 4% in dollars. Local currency fine fragrance sales increased 10%, driven primarily by new wins, while functional fragrances and aroma chemicals declined 5% and 3%, respectively. Local currency flavor sales declined 22% and 19% in dollars mainly as a result of the disposition of the fruit preparations business. On an as-adjusted basis, excluding sales attributable to this business from the 2004 results, 2005 flavor sales would have increased 3% in dollars and been flat in local currency. On the same as-adjusted basis, sales in Eastern Europe increased 13% in local currency, led by a 33% increase in Russia; however, this performance was offset by a local currency decline of 1% in Western Europe.
- Asia Pacific sales were flat in local currency and increased 2% in dollars. Fragrance sales decreased 4% in local currency and 3% in dollars; flavor sales increased 3% in local currency and 5% in dollars. Flavor sales were strongest in Greater China, Indonesia and Vietnam, with respective local currency increases of 14%, 11% and 34%. Fragrance sales in Vietnam, Taiwan and South Korea increased 66%, 18% and 15%, respectively, but were offset by declining sales in Thailand and Singapore/Malaysia.
- Latin American sales increased 10% in comparison to the prior year. Flavor sales increased 18%, benefiting from increases of 20%, 23% and 35% in Argentina, Brazil and Mexico, respectively. Fragrance sales increased 7% with Argentina, Mexico and Brazil reporting increases of 14%, 5% and 8%, respectively.
- India sales increased 16% in local currency and 17% in reported dollars. This performance was led by an 18% local currency increase in flavor sales with fragrance sales increasing 14% in comparison to the prior year period. In both flavors and fragrances, the sales performance reflected the benefit of new wins.
Net income for the nine-month period ended September 30, 2005 increased 15% compared to the prior year period; excluding the impact of restructuring and other charges from the 2004 results and the tax benefit from AJCA from the 2005 results, net income decreased 11%. The 2005 decline in net income is partially due to the disposition of the European fruit business; 2004 results included income of $4.0 million attributable to this business. Proceeds from the disposition were used to reduce debt but profits related to the Fruit business were not replaced by interest expense savings.
Gross profit, as a percentage of sales, was 41.6% compared to 43.0% in the prior year period; the margin decline was mainly attributable to higher raw material costs which the Company has not yet been able to fully recover through increased selling prices. Gross margin was also negatively impacted by costs attributable to the raw material contamination issue the Company reported earlier this year; year-to-date, cost of sales include $3.0 million in related costs, comprised mainly of testing costs and the write-off of affected materials. R&D expenses totaled 8.7% of sales compared with 8.4% in the prior year period, consistent with the Company's intended level of R&D spending. SG&A expenses, as a percentage of sales, increased to 16.6% from 16.4%, mainly due to the cost of customer damages related to the raw material contamination issue. Interest expense decreased 2% from the prior year mainly due to lower average borrowings compared to the prior year. The effective tax rate for the nine-month periods ended September 30, 2005 and 2004 was 20.8% and 30.9%, respectively; excluding the impact of AJCA, the effective tax rate for the nine-month period ended September 30, 2005 would have been 31.2%. Variations in the effective tax rate are mainly attributable to fluctuations in earnings in the countries in which the Company operates.
Outlook for 2005
IFF currently expects 2005 local currency sales to decrease in the low single digits in comparison to 2004 sales as reported; based on current exchange rates, such local currency performance is expected to result in a low single digit decrease in reported dollars. For purposes of this comparison, 2004 sales include $58 million of sales attributable to the European fruit preparations business. Excluding fruit sales from the 2004 comparative, IFF expects 2005 local currency sales to be flat to up 1% in comparison to 2004; based on current exchange rates, this local currency growth is expected to result in a low single digit increase in reported dollars.
Gross profit as a percentage of sales is expected to remain at approximately the same levels as reported for the first nine months, mainly due to increased supply chain costs including the impact of the raw material costs, as well as the timing in implementing negotiated price increases. R&D expenses are expected to approximate 9% of sales, consistent with the Company's intended level of R&D spending. R&D spending is increasing as a percentage of sales in comparison to 2004, mainly as a result of the elimination of the fruit preparations business; relative to other parts of the business, fruit preparations required less R&D as a percentage of sales. In 2005, SG&A expenses, as a percentage of sales, are expected to increase somewhat from 2004 levels, mainly from inclusion of an expected $12.0 million - $13.0 million in equity compensation expense in 2005, compared to $5.0 million of such expense in 2004. In May 2004, the Company began using Restricted Stock Units ("RSU's"), rather than stock options, as an element of the Company's incentive compensation plans for all eligible U.S. - based employees and a majority of eligible overseas employees. The actual expense will depend upon the value of the Company's stock and the number of RSU's granted. The cost of customer damages related to the raw material contamination issue will also impact SG&A expense. The Company expects the effective tax rate in 2005 to be 23.0%; excluding the benefit attributable to AJCA, the effective tax rate is expected to be 31.2%.
Based on the foregoing, IFF currently expects earnings per share for 2005 to be in the range of $2.26 to $2.34, including the per share effect of the tax benefit related to AJCA of $.24. These results compare to earnings per share of $2.05 reported in 2004; excluding restructuring and other charges representing $.22 per share, 2004 results per share were $2.27.
About IFF
IFF is a leading creator and manufacturer of flavors and fragrances used in a wide variety of consumer products -- from fine fragrances and toiletries, to soaps, detergents and other household products, to beverages and food products. IFF is dedicated to The Pursuit of Excellence in every area of its business, using knowledge, creativity, innovation and technology to continually provide customers with the highest quality products and service and superior consumer understanding.
IFF has sales, manufacturing and creative facilities in 31 countries worldwide. For more information, please visit our Web site at http://www.iff.com.
Cautionary Statement Under the Private Securities Litigation Reform Act of 1995
Statements in this report, which are not historical facts or information, are "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on management's reasonable current assumptions and expectations. Certain of such forward-looking information may be identified by such terms as "expect," "believe," "may," "outlook," "guidance" and similar terms or variations thereof. All information concerning future revenues, tax rates or benefits, interest savings, and other future financial results or financial position, constitutes forward-looking information. Such forward-looking statements are based on management's reasonable current assumptions and expectations. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management's expectations. Such factors include, among others, the following: general economic and business conditions in the Company's markets, including economic, population health and political uncertainties; interest rates; the price, quality and availability of raw materials; the Company's ability to implement its business strategy, including the achievement of anticipated cost savings, profitability and growth targets; the impact of currency fluctuation or devaluation in the Company's principal foreign markets and the success of the Company's hedging and risk management strategies; the outcome of uncertainties related to litigation; uncertainties related to any potential claims and rights of indemnification or other recovery for customer and consumer reaction to the contamination issue; the impact of possible pension funding obligations and increased pension expense on the Company's cash flow and results of operations; and the effect of legal and regulatory proceedings, as well as restrictions imposed on the Company, its operations or its representatives by foreign governments. The Company intends its forward-looking statements to speak only as of the time of such statements and does not undertake to update or revise them as more information becomes available or to reflect changes in expectations, assumptions or results.
|